Fig. 1From: Prospective, randomized, double-blind trial to investigate the efficacy and safety of corneal cross-linking to halt the progression of keratoconusConsort flow-chart. Three patients had an incomplete follow-up of one year. The data were included in the analysis. One patient belonged to the treatment arm, the other two to the placebo groupBack to article page